Evaluation of 3D Selection Tasks in Parabolic Flight Conditions: Pointing Task in Augmented Reality User Interfaces
NCT ID: NCT02563236
Last Updated: 2015-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2012-03-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Experimental protocol
\---------------------------- Before flight subjects will be familiarized with the setup and the protocol. For each flight day, 2 subjects will be studied one for each AR device. Halfway during the flight, the 2 subjects will swap places. The procedure will be the following on all 3 days.
The experiment day will start at 7.30 a.m. with the test subjects equipped with heart rate recording device. After take-off and after work will be permitted, the 2 subjects will go to the experimental area where they will be seated. They will be equipped with one of the HMD (optical- or video-see through HM). During a parabola the subjects perform the experimentation task: symbolic input of five letters onto virtual keyboard depending on the experimental task during a parabola.
To point towards the virtual keyboard the subject wears a thimble on his forefinger. The body-alignment scenario requires an additional panel on subject's non-dominant hand.
During a parabola two subjects perform the tasks - one is using HMD type 1 in hyper-g and the other subject is using HMD type 2 in micro-g.
During the 8 minute rest period between parabolas 15 and 16, the 2 test subjects will switch places. Switching place will be a straightforward process as each member of our team has expertise in manning the test equipment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parabolic flight and Augmented Reality interface alignments
Parabolic flight
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parabolic flight
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged from 21 to 55
* Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC)
* Who accepted to take part in the study
* Who has already experience in handling specific AR interfaces while wearing an HMD
* Who have given their written stated consent
* Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude. There will be no additional test performed for subject selection.
Exclusion Criteria
* Pregnant women
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Umr Ucbn/Inserm U1075 Comete
Caen, Basse-Normandie, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-022
Identifier Type: -
Identifier Source: org_study_id